Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
Sponsor: Fred Hutchinson Cancer Center
Summary
This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.
Official title: ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation
Key Details
Gender
All
Age Range
18 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
1372
Start Date
2026-04-30
Completion Date
2027-10-31
Last Updated
2026-04-08
Healthy Volunteers
Yes
Interventions
Smartphone app
Receive access to the ACT on Vaping app
Smartphone app
Receive access to the ACT on Vaping app
Text Message
Receive incentivized text messages to access vaping status
Text Message
Receive intervention text messages
Survey Administration
Ancillary studies
Locations (1)
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States